Tumor hypoxia is a common characteristic of most solid tumors and is correlated with poor prognosis for patients partly because hypoxia promotes resistance to cancer therapy. Hypoxia selects cancer cells that are resistant to apoptosis and allows the onset of mechanisms that promote cancer cells survival including autophagy. Previously, we showed that human hepatoma HepG2 cells were protected under hypoxia against the etoposide-induced apoptosis.
Introduction
Tumor hypoxia is recognized as a poor prognosis factor associated with resistance to cancer therapy such as radiotherapy and chemotherapy [1, 2] . Inside the tumor, oxygen supply is compromised by the inadequate blood flow due to the abnormal vasculature network and by the high rate of cancer cell proliferation. Indeed, cancer cell proliferation also contributes to hypoxia by increasing the interstitial pressure and the diffusion distance from the blood vessels. Cancer cells localized in hypoxia areas are more resistant to chemotherapy than cells in well-oxygenated zones because drug delivery in hypoxia areas is limited and because oxygen is required for the cytotoxicity of some drugs [3] . Besides direct effects, hypoxia also promotes cancer cell resistance against chemotherapy by inducing adaptive mechanisms to hypoxia [4] . Regulation of gene expression, involving HIF-1, is an important component of the initiation of these adaptive responses to hypoxia. HIF-1 regulates the expression of over a hundred of genes and among them are genes encoding proteins involved in the regulation of angiogenesis, erythropoiesis, anaerobic metabolism, drug resistance and proliferation. In addition, cell survival and cell death are both regulated by hypoxia, in part through the regulation of programmed cell death I and II processes named apoptosis and autophagy respectively. The regulation of apoptosis by hypoxia involves the regulation of the expression of genes such as Bid, Bax, Noxa, Survivin and Mcl-1 [5] [6] [7] [8] . In addition, hypoxia selects cancer cells with reduced apoptotic potential [9] . Autophagy is first a cellular response in which proteins, organelles and portions of cytoplasm are engulfed, digested and recycled to sustain cellular metabolism during stress such as nutrient starvation and hypoxia [10] .
Although stimulation of autophagy might constitute a protective response, extensive and non regulated autophagy may lead to cell death which may be either independent or linked to apoptosis [11] .
A c c e p t e d M a n u s c r i p t 4 Under hypoxia, the induction of autophagy is mainly due to the hypoxia-inducible protein BNIP3, encoded by a HIF-1 target gene. BNIP3 belongs to the BH3-only Bcl-2 family and contains a BH3 domain and a transmembrane domain that targets BNIP3 to the outer mitochondrial membrane. Unlike other BH3-only proteins, interactions with other proteins as well as its functions depend on the transmembrane domain but not on the BH3 domain [12] .
Before its role in autophagy was discovered, BNIP3 was associated with cell death by multiple mechanisms. Currently, it seems that BNIP3 may participate in cell death by inducing necrosis, apoptosis or autophagy. In some cases, localization of BNIP3 into the outer mitochondrial membrane causes an increase in ROS production, cytochrome c release by PTP opening, loss of m and leads to caspase-dependent cell death [13] . Bax and Bak seem to be essential for BNIP3-induced cell death characterized by apoptosis features [14] . Caspaseindependent cell death through the release of endoG but not of cytochrome c was also observed following BNIP3 insertion into the outer mitochondrial membrane [15] . Finally, BNIP3 can also induce autophagic cell death. However, the precise mechanisms involved are still poorly understood. It seems that BNIP3 could be involved in autophagosome-lysosome fusion or in earlier stages such as Beclin-1 activation and mTOR inhibition [10, 16, 17] .
Finally, BNIP3 has been linked to protective autophagy and cell survival [10, 18] .
We have previously shown that human hepatoma HepG2 cells could be protected against etoposide-induced apoptosis under hypoxia. Given the potential role of both autophagy and BNIP3 in the regulation of cell death and cell survival, we investigated their putative role in etoposide-induced cell death and the protection provided by hypoxia. siRNA were used as negative control.
Caspase-3 activity assay
The fluorogenic substrate Ac-DEVD-AFC (BD Biosciences, San Diego, USA) was used to measure caspase-3 activity according to Lozano et al [19] . Cell extracts were prepared as described by Wellington et al [20] . Cells were seeded in 6-well plates (250,000 cells/well).
The assay for caspase-3 activity was performed according to Cosse et al [21] .
LDH release assay
LDH release was measured with the cytotoxicity detection kit from Roche Molecular Biochemical (Basel, Switzerland) according to the manufacturer's protocol.
Real time RT-PCR
At the end of the incubation, total RNA was extracted using the Trizol extraction kit (Invitrogen, Carlsbad, USA). mRNA contained in 2 µg total RNA was reverse transcribed ACCAAGTCAGACTCCAGTTCTTCA). Amplification reaction assays contained 1x SYBR Green PCR Mastermix (Applied Biosystem, Carlsbad, USA) and primers (Applied Biosystem, Carlsbad, USA) at the optimal concentrations. RPL13A was used as the reference gene for normalization and mRNA expression level was quantified using the threshold cycle method.
Statistical analysis
Statistical analyses were performed using Student's t test using SigmaStat software (Jandel Scientific Software). For each set of data, real triplicates were performed in one experiment.
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Results

Hypoxia protects HepG2 cells against etoposide-induced apoptosis
We have previously shown that hypoxia protects HepG2 cells against etoposide-induced apoptosis [21] [22] [23] . To confirm these results, cells were incubated for 16 h in serum freemedium in the presence or in the absence of etoposide, under normoxia (21% O 2 ) or under hypoxia (1% O 2 ). At the end of the incubation, cells were fixed and nuclei were labelled with DAPI and observed with fluorescent microscopy ( Figure 1A ). We observed nuclear fragmentation in cells exposed to etoposide under normoxia but not in cells exposed to etoposide under hypoxia nor in cells that were not incubated with etoposide whatever the pO 2 .
In addition, the cleavage of PARP-1 was assessed by Western blot ( Figure 1B ). Etoposide induced the cleavage of PARP-1 and hypoxia prevented the cleavage of the protein. Hypoxia per se had no effect on the cleavage of PARP-1. In conclusion, as previously shown, etoposide induces apoptosis while hypoxia, a condition that does not affect apoptosis, protects cells against etoposide-induced apoptotic cell death.
Effects of hypoxia and/or etoposide on autophagy
Autophagy is known to be a cellular response to energy-limiting stresses such as serum deprivation. Moreover, it has been described that some chemotherapeutic drugs can also induce autophagy [24, 25] . In order to evaluate the effect of hypoxia and/or etoposide on autophagy, cells were incubated for 16 h with or without etoposide under normoxia or under hypoxia. At the end of the incubation, the presence of autophagic vacuoles was assessed using transmission electron microscopy ( Figure 2A ). Despite being incubated 16 hours in serumfree medium, basal autophagy induced by these conditions remained low (Figure 2A , Nx). We observed that etoposide increased the number of autophagosomes in cells treated with etoposide both under normoxia and under hypoxia. In addition, the incorporation of the A c c e p t e d M a n u s c r i p t 11 autofluorescent marker Monodansylcadaverine (MDC) has been assessed ( Figure 2B ). MDC was first described as a specific marker of autophagic vacuoles [26, 27] . However, subsequent studies have suggested that MDC is not a specific marker for early autophagosomes [28, 29] .
We observed that the MDC-associated fluorescence was higher in cells treated with etoposide than in control cells. Very low difference was observed between cells under hypoxia and cells under normoxia, independently of the presence of etoposide. To confirm these results, the conversion of LC3-I to LC3-II has been investigated. LC3 is the human homolog of yeast Atg8. LC3-I is obtained by the cleavage of nascent LC3 (proLC3) by Atg4 and is located in cytosol. During autophagy, LC3-I is involved in the formation of autophagosome and is incorporated into the autophagic vacuole membrane. For this, LC3-I must be conjugated to phosphatidylethanolamine (PE) by Atg7. PE-conjugated LC3-I is called LC3-II [30] .
Although the molecular weight of LC3-II is larger than the weight of LC3-I due to the conjugation to PE, LC3-II migrates faster than LC3-I in SDS-PAGE due to its higher hydrophobicity. Therefore, LC3-I and LC3-II are usually detected in SDS-PAGE at a molecular mass around 16 kDa and 14 kDa respectively [31] . Cellular extracts were prepared from cells incubated with or without etoposide, under normoxia or under hypoxia for a period ranging from 2 to 24 hours and the level of both forms of LC3 was assessed by Western blot Under hypoxia, the abundance of total LC3 decreased as previously observed by Western blot. It is known that LC3-II is located both in the inner and the outer membrane of autophagic vacuoles [32] . After autophagosome-lysosome fusion, the fraction of LC3-II that is located in the inner membrane is degraded while the fraction of LC3-II located in the outer membrane is released in the cytosol and converted back in LC3-I, so the decrease of total LC3 protein level may be due to a higher autophagic rate. However, we did not observe any differences between autophagy under hypoxia and autophagy under normoxia in the presence of etoposide although the rate of autophagy is difficult to assess through the conversion of LC3 as long term exposure to hypoxia alters the abundance of the protein. In addition, following treatment with bafilomycin A1 which blocks autophagosomelysosome fusion, the abundance of total LC3 was higher in normoxic cells than in hypoxic cells ( Figure 3C ). This indicates that the difference in the abundance of total LC3 between normoxia and hypoxia was not due to change in the autophagic rate. Therefore, we postulated Figure 3D ). We observed that the abundance of total LC3 is reduced under normoxia in cells treated with cycloheximide. This confirms our hypothesis that difference in LC3 level between normoxia and hypoxia was not due to a change in autophagic rate between these conditions but to a decrease in protein synthesis under hypoxia.
Differential effect of etoposide-induced autophagy under normoxia compared to hypoxia
We have shown that etoposide induced autophagy while hypoxia had no effect on the etoposide-induced autophagy. We have also evidenced that the resistance of HepG2 cells It should be noted that the inhibition of autophagy by the silencing of Atg5 did not increase M a n u s c r i p t 14 the total LC3 abundance under hypoxia to the total abundance of LC3 under normoxia, a data again supporting the fact that the lower total abundance of LC3 under hypoxia is independent of autophagy. Then, we studied the effect of autophagy inhibition on the etoposide-induced apoptosis by following caspase-3 activity using a fluorogenic substrate ( Figure 4B ). The cleavage of Ac-DEVD-AFC substrate was increased by etoposide while hypoxia inhibited these effects. Interestingly, the silencing of Atg5 reduced the cleavage of Ac-DEVD-AFC substrate under normoxia. In contrast, Atg5 silencing did not affect the cleavage of Ac-DEVD-AFC substrate under hypoxia. In conclusion, autophagy seems to promote etoposideinduced cell death markers of apoptosis under normoxia. By contrast, autophagy does not seem to affect the protective effect of hypoxia although, even if in some cases, it appears to have a weak protective effect. These results were confirmed by measuring overall viability. Figure 4C ).
LDH release was investigated in cells incubated for 40 hours with etoposide (
Etoposide increased LDH release while hypoxia reduced the etoposide-induced LDH release.
The silencing of Atg5 reduced the etoposide-induced LDH release under normoxia and did not modify the etoposide-induced LDH release under hypoxia, indicating that autophagy could promote etoposide-induced cell death under normoxia but would not have any effect under hypoxia. Generally, negative control siRNA had no or little influence on studied parameters. Altogether, these results indicate that autophagy does not modulate the protection against etoposide conferred by hypoxia.
Effect of BNIP3 on the resistance against etoposide-induced apoptosis under hypoxia
To explain why etoposide-induced autophagy does not have the same consequences under normoxia and under hypoxia, we investigated the role of BNIP3, a hypoxia-induced protein for which an involvement in autophagy has been clearly demonstrated [16] . BNIP3 is a BH3-only protein encoded by a HIF-1-target gene [33] . As expected, the protein and mRNA levels of BNIP3 are increased under hypoxia in HepG2 ( Figures 5A and 5B ). In contrast, etoposide A c c e p t e d M a n u s c r i p t 15 seemed to slightly reduce protein and mRNA levels but also to limit the upregulation of BNIP3 by hypoxia. BNIP3 has been associated with cell death by necrosis, apoptosis and autophagy. Moreover, a protective role has been conferred to BNIP3 in part through the upregulation of autophagy [10] . To determine the putative role of BNIP3 on autophagy and apoptosis in the protection conferred by hypoxia, the expression of BNIP3 was silenced using specific siRNA. A decrease in BNIP3 mRNA of 91 % was observed under hypoxia (data not shown). The impact of the silencing of BNIP3 on autophagy was determined by assessing the abundance of LC3-I and LC3-II by Western blot ( Figure 5C ). BNIP3 silencing had no effect on the abundance of both forms of LC3, suggesting that it does not influence autophagy in these experimental conditions. The possible involvement of BNIP3 in apoptosis was determined by following caspase-3 activity. We observed that caspase-3 activity was not affected by the silencing of BNIP3 under normoxia ( Figure 5D ). In contrast, the silencing of 
Discussion
Our recent studies have demonstrated that hypoxia protects human hepatoma HepG2 cells against etoposide-induced apoptosis ( Figures 1A and 1B) [8, [21] [22] [23] . Hypoxia is an energylimiting stress which can leads to autophagy upregulation. Autophagy starts with the formation of an autophagosome, enclosed within a double membrane that engulfs part of cytoplasm. The formation of autophagosome depends upon Atg proteins [34] . Autophagy can be stimulated by various stresses, including nutrient depletion or hypoxia. In this case, autophagy is used to provide the constituents required to maintain metabolism essential for cell survival or to promote cell death, suggesting a dual role of autophagy [35] [36] [37] .
Connections between autophagy and apoptosis have been identified. It has been shown that autophagy can either collaborate with apoptosis either to promote cell death or to prevent apoptotic cell death [38] [39] [40] [41] .
Therefore, we sought to evaluate the role of autophagy in the etoposide-induced apoptosis and the protective effect of hypoxia on it. To evaluate the autophagic rate, autophagosomes were observed by transmission electron microscopy and MDC-labelling ( Figures 2A and 2B ). In addition, LC3-I and LC3-II protein level and localization of LC3-GFP were studied ( Figures   3A and 3B ). We observed that autophagy was enhanced by etoposide. The upregulation of autophagy by chemotherapeutic drugs has already been described [42] [43] [44] [45] [46] [47] . Chemotherapyinduced autophagy may promote cell resistance against it. Doxorubicin-induced DNA damage stimulates cytoprotective autophagy through a PARP-1-dependent pathway [48] . Similarly, cisplatin-induced autophagy delays apoptosis in renal tubular epithelial cells [45] and tamoxifen and camptothecin-induced autophagy increases MCF7 breast carcinoma cell line viability [42, 46] . Examples of autophagic cell death in response to chemotherapy were also described. Vitamin D analogue, EB1089, kills MCF7 through the induction of massive autophagy [43] while arsenic trioxide induces autophagic cell death in human malignant A c c e p t e d M a n u s c r i p t 17 glioma cell lines [44] . Autophagic cell death is also an alternative cell death pathway to apoptosis when it is no longer functional. Indeed, etoposide-induced autophagic cell death was described in apoptosis-deficient mouse embryonic fibroblasts [47] . We then investigated the impact of hypoxia on the etoposide-induced apoptosis. The results showed that hypoxia had no effect by itself on autophagy and did not modify the etoposide-induced autophagy ( Figures 3A and 3B ). This is surprising and inconsistent with the literature in which the regulation of autophagy by hypoxia is well documented. Indeed, Papandreou et al. have
shown that hypoxia induces autophagy through the AMPK activation [49] but the main mechanism of induction of autophagy by hypoxia requires HIF-1 and BNIP3 [10, 16] . The reason of this discrepancy is not known. It is however known that the level of pO 2 may influence the induction of autophagy by hypoxia [50] .
Although the etoposide-induced autophagy rate under normoxia and under hypoxia was similar, it is conceivable that autophagy plays a role in the protective effect of hypoxia. As mentioned previously, autophagy can lead to cell death, possibly by cooperating with apoptosis, or can promote cell survival by providing the constituents required to maintain metabolism essential for survival. Furthermore, autophagy may antagonize apoptosis through the elimination of depolarized mitochondria to prevent the release of apoptogenic factors such as AIF and cytochrome c from damaged mitochondria [35, 38] . To better delineate the role of autophagy in the etoposide-induced cell death and to determine whether or not there were differences between etoposide-induced autophagy under hypoxia and under normoxia, we inhibited autophagy. For this, Atg5 expression was silenced using specific siRNA. Atg5 is a component of the Atg12-Atg5 conjugation system required for the process of autophagosome formation. The effect of Atg5 silencing on autophagy was evaluated by studying the abundance of both forms of LC3. This marker of autophagy is appropriate to study the inhibition of autophagy due to Atg5 silencing since it has been shown that the LC3-I A c c e p t e d M a n u s c r i p t 18 conversion to LC3-II was downstream the Atg12-Atg5 conjugation and required Atg5 [30] .
The silencing of Atg5 inhibited autophagy as LC3-II level decreased and LC3-I level increased in these conditions ( Figure 4A ). To determine the effect of autophagy inhibition on etoposide-induced apoptosis, the activity of active caspase-3 as well as cell viability were studied ( Figures 4B and C) . Atg5 silencing reduced the etoposide-induced apoptosis under normoxia but did not influence it under hypoxia. This means that autophagy contributes to etoposide-induced apoptosis under normoxia and acts upstream of apoptosis. In contrast, autophagy had no effect neither on the etoposide-induced apoptosis under hypoxia, nor on the protection conferred by hypoxia. The inhibition of the expression of Atg5 gene with siRNA has already been reported to promote resistance to chemotherapy [51, 52] . However, it has been reported that Atg5 might be cleaved by calpains and truncated Atg5 could stimulate apoptosis by direct interaction with Bcl-XL in the mitochondrial outer membrane [53] . We can not exclude this possibility.
BNIP3 is a BH3-only Bcl2 family member encoded by a HIF-1 target gene [33] . Many studies have reported that BNIP3 expression induces cell death with features that are both consistent and inconsistent with apoptosis suggesting that BNIP3 induces cell death through multiple pathways including apoptosis, necrosis and autophagy according to cell lines and conditions [13] [14] [15] 44] . Indeed, BNIP3-induced cell death is related to mitochondrial dysfunction, membrane depolarization, permeability transition pore opening and increased generation of ROS according to the experimental conditions. Both caspase-dependent and caspase-independent forms of cell death have been related to BNIP3. In some cases, BNIP3-induced cell death was associated with the appearance of autophagic vacuoles and cellular morphological features of necrosis [54] . On the other hand, BNIP3-induced autophagy was described as a survival mechanism, providing time and resources for cell adaptation. hypoxia by preventing an increase in ROS levels [10] . Bcl-2 family pro-survival members inhibit autophagy by sequestering Beclin-1, a protein required for initiating autophagy [55] .
Indeed, BNIP3 promotes autophagy by displacing Beclin-1 from Bcl-2 [10] . The involvement of BNIP3 in other steps of autophagy has also been described. It seems that BNIP3 can induce autophagy by interacting with RheB, resulting in mTOR inhibition [17] . Moreover, the involvement of BNIP3 in later stages of autophagy, such as autophagosome-lysosome fusion, has also been described [16] . In this work, we have studied the involvement of BNIP3 in the protective effect of hypoxia against apoptosis for several reasons. First, the expression of BNIP3 is linked to hypoxia and HIF-1 [33] . Secondly, BNIP3 is involved both in cell death as in cell survival [10, 13, 14, 54] . Thirdly, BNIP3 is a connection between apoptosis and autophagy [10] . To study the role of BNIP3, the expression of BNIP3 was silenced using siRNA. The study of LC3-I and LC3-II proteins level showed that BNIP3 did not affect the etoposide-induced autophagy whatever the pO 2 level ( Figure 5C ). Moreover, BNIP3 silencing had no effect on etoposide-induced apoptosis under normoxia as caspase-3 activity was not affected by BNIP3 silencing ( Figure 5D ). In contrast, BNIP3 silencing increased caspase-3 activity under hypoxia, indicating that BNIP3 is involved in the protection conferred by hypoxia against the etoposide-induced apoptosis. In the literature, the role of BNIP3 in cell survival is clearly linked to its function in regulating autophagy. However, in HepG2 cells with the experimental conditions used, we showed that the protective effect of BNIP3 is independent of autophagy. Similarly, a recent report mentioned a protective effect of BNIP3 by a mechanism independent on autophagy. Indeed, Burton et al. have shown that BNIP3 is located in the nucleus and acts as transcriptional repressor of apoptosis-inducing factor (AIF)
gene, in association with PSF and HDAC1, in human glioma U251 and U87 cells [56] .
Further studies are thus needed to investigate how BNIP3 can inhibit apoptosis under hypoxia.
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In conclusion, we observed that hypoxia protects HepG2 cells against etoposide-induced apoptosis by the induction of BNIP3. BNIP3 is shown to be induced by hypoxia by a HIF-1-dependent manner and to promote autophagy that can lead to cell death or cell survival according to the experimental conditions. In HepG2 cells, we observed that autophagy is induced by etoposide but not by hypoxia. Moreover, we observed that autophagy has a dual role as it promotes etoposide-induced apoptosis under normoxia but not under hypoxia.
Finally, we showed that BNIP3 does not regulate autophagy and protects HepG2 against etoposide-induced apoptosis by an autophagy-independent mechanism ( Figure 6) . Etoposide induces DNA double strand breaks (DSB) and causes apoptosis and cell death.
Hypoxia protects cells against etoposide-induced apoptosis. Autophagy is induced by etoposide both in normoxic and hypoxic cells. In normoxic cells, autophagy contributes to etoposide-induced apoptotic cell death. In contrast, autophagy has no effect on etoposideinduced apoptotic cell death and on the protective effect conferred by hypoxia. BNIP3 is
